UK markets closed

Compugroup Medical SE & Co. KGaA (0MSD.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
66.20+2.20 (+3.44%)
At close: 5:50PM BST
Full screen
Loading interactive chart…
  • EQS Group

    CompuGroup Medical also well on track in second quarter

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Half Year Results/Quarter Results 06.08.2020 / 08:10 The issuer is solely responsible for the content of this announcement. \- 6% organic growth yoy excluding Telematics Infrastructure\- Significant increase in recurring revenues across all segments\- Higher revenues expected in second half 2020 due to approval of e-health connector \- Full year guidance raised \- Additional headroom for growth due to share placement Koblenz. CompuGroup Medical (CGM) is looking back once again at a solid quarter. Although the second quarter of 2020 was significantly affected by the economic impact of the COVID-19 pandemic, Koblenz based CompuGroup Medical, one of the largest providers of e-Health solutions worldwide, is well on track financially. CGM is expecting continued positive business performance due to increasing digitizing in healthcare and corresponding measures by the government and the economy. Against this background, CGM is well set to continue the current investment and growth path, supported by a share placement at the end of June resulting in gross proceeds of approximately EUR 341 million.Frank Gotthardt, founder and CEO of CompuGroup Medical, "Our company showed its strong resilience and solid business model in the face of uncertainties of a pandemic in the first and especially in the second quarter. We have seen many people becoming directly aware of the benefits of digitization in healthcare during this time. In the third quarter, healthcare professionals and patients will be able to benefit even more from the opportunities of digital communication. Since the CGM e-health connector KoCoBox MED+ has been approved and is now being rolled out, emergency data and electronic medication plans on a health card will become normal along with digital communication between service providers. All of this encourages us to continue with our consistent growth course from past years."Group: Stable performance and positive outlook Overall, CGM was fully on track in the second quarter and generated group revenues of EUR 179.9 million. Adjusted EBITDA grew by 1% to EUR 44.6 million year-on-year. The prior year quarter had been characterized by high installation revenues for the Telematics Infrastructure (TI) in German doctors' practices with revenues of EUR 186.6 million. Without these TI one-time revenues, group revenues grew organically by 6% in spite of the effects and uncertainties from COVID-19, and recurring revenues significantly increased by 10%. Due to the July 2020 approval of KoCoBox MED+ as an e-health connector, CGM expects good one-time revenues in the second half of the year from the software upgrade in more than 55,000 practices. In addition, the rollout of the Telematics Infrastructure can now begin in pharmacies.Adjusted Group EBITDA increased from EUR 44.3 million (pro-forma) to EUR 44.6 million in the second quarter of 2020. The operating margin is still at a high level with 25% (previous year: adjusted 24%). CGM generated a consolidated profit of EUR 16.3 million in the second quarter (previous year: EUR 14.2 million). Adjusted earnings per share (diluted) were EUR 0.38, exactly at the previous year's level of EUR 0.38 in spite of the increased number of shares outstanding following the share placement.Capital expenditures stood at EUR 13.5 million, slightly below the previous year (EUR 14.3 million). Operating cash flow in the reporting period was characterized by a decrease in payables and an increase in inventory and income tax receivables. Adjusted free cash flow was at EUR -0.8 million (previous year EUR 23.5 million), which is primarily due to high, one-off payments from TI connections in the previous year. Net debt as of June 30, 2020 was at EUR 123.2 million and thus EUR 343.7 million lower versus year-end 2019 (EUR 466.9 million). As of June 30, 2020, the company employed 5,826 people, 369 more than at the end of the previous year quarter. Including the successfully concluded takeover of the Cerner portfolio, which took place after the reporting date of June 30, 2020, the company employs more than 6,100 people.CGM is increasing its guidance for the full year. Including the acquisition of parts of the Cerner portfolio in Germany and Spain, which was finalized on July 1, revenues are now expected in the range of EUR 820 million to EUR 860 million. Guidance for adjusted EBITDA is also raised to a new range of EUR 205 million to EUR 220 million.Segments: All segments are growing recurring revenue Revenues in the Ambulatory Information Systems segment were down 9% year-on-year because of the especially high sales from the TI rollout in the previous year quarter as a one-off effect. Recurring revenues significantly increased year-on-year by 8% to EUR 81.4 million, representing 77% of total segment revenues. Organic revenue growth excluding TI stood at 7% in the second quarter of 2020.Business in the Pharmacy Information Systems (PCS) segment was positively affected in the second quarter by successful sales of additional modules for cashpoints in German pharmacies. Revenues increased by 6% to EUR 29.6 million (previous year: EUR 27.8 million). Recurring revenues increased by almost 9% year-on-year and reached EUR 18.9 million. The share of recurring revenues increased by one percentage point to 64% of the segment's revenues. Revenues also increased organically by approximately 6%. Adjusted EBITDA was EUR 8.0 million (previous year: EUR 6.0 million) with an operating margin of 27% (previous year: 21%).The Hospital Information Systems (HIS) segment increased revenues in the second quarter by 4% to EUR 33.4 million (previous year: EUR 32.3 million). Recurring revenues increased by 12% to EUR 21.8 million. Thus, the portion of recurring revenue in the segment's revenues increased from 60% to 65%. Adjusted EBITDA was EUR 5.5 million after EUR 1.6 million in the previous year quarter, which is an increase of the operating margin to 16% (previous year: 5%).The Consumer & Health Management Information Systems (CHS) segment increased revenues by 6% to EUR 10.6 million (previous year: EUR 9.9 million), which mainly resulted from the CGM LIFE division that significantly increased its business with private health insurance companies. Organic growth was also 6%. Adjusted EBITDA of EUR 1.4 million was slightly under the previous year quarter (EUR 1.5 million) due to increased development costs.The complete half year report is available on the company's website at www.cgm.com under Investor Relations. About CompuGroup Medical SE & Co. KGaA CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of EUR 746 million in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.5 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 6,100 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system. Contact for media representatives: Michael Franz Head of Brand Communication P +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 E-mail: press@cgm.comContact for analysts and investors: Claudia Thomé Head of Investor Relations P +49 (0) 261 8000-7030 F +49 (0) 261 8000-3200 E-mail: claudia.thome@cgm.com * * *06.08.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: CompuGroup Medical SE & Co. KGaA Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE000A288904 WKN: A28890 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1111395 End of News DGAP News Service

  • EQS Group

    CompuGroup Medical SE & Co. KGaA: CompuGroup Medical further drives digitization in healthcare: first e-health connector approved

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous 22.07.2020 / 11:02 The issuer is solely responsible for the content of this announcement. Koblenz. Today, KoCoBox MED+ from CompuGroup Medical Deutschland AG (CGM), the first e-health connector received approval from gematik for a nationwide rollout. KoCoBox MED+, which is well-known and installed tens of thousands of times in Germany, will therefore receive an e-health software upgrade for the new Telematics Infrastructure (TI) medical applications without any hardware replacement need. With this update, Emergency Data Management (NFDM) and the Electronic Medication Plan (eMP) will provide noticeable added value for patients who receive medical treatment in more than 55,000 medical and dental practices. The approval now also allows CGM installations in pharmacies. CGM has already received about 3,000 orders, whose implementation can now begin immediately."The right medical information in the right place at the right time can save people's lives, prevent suffering and help to heal diseases," emphasizes Frank Gotthardt, Founder and CEO of CompuGroup Medical. "The e-health upgrade creates long-term added value for health professionals as well as for patients by making important and in many cases life-saving data available exactly where it is needed. We are pleased that with KoCoBox MED+ we can offer our customers an extremely reliable e-health connector, which has been intensively tested in the field with numerous customers. This device has also proven to be highly resilient in regular operation for Insured Person's Master Data again - a testimony to our years of heavy investment in safety and technological progress."With the patient's consent, Emergency Data Records or an Electronic Medication Plan can be stored on the Electronic Health Card for the first time and, if necessary, read out by the attending practitioner - doctor, dentist or pharmacist. Both applications have been extensively tested in a field test in the Westphalia-Lippe region in the past months. CGM KoCoBox MED+ had been upgraded to an e-health connector. A connection to the Telematics Infrastructure with this kind of an e-health connector is necessary so that these new, value-added medical applications can find their way into practices, pharmacies or clinics. CGM is the first provider to receive approval from gematik for an e-health connector with the KoCoBox MED+ upgrade.Dr. Eckart Pech, Managing Director for the Consumer and Health Management Information Systems Division at CompuGroup Medical: "Our customers - doctors, dentists, clinics and pharmacies - will be the first applicants to use the new added-value medical services in the TI and benefit from the funding and additional fees provided for this. Now that final approval exists, we will begin to make the e-health upgrade for the KoCoBox MED+ available to our TI customers. No hardware exchange is necessary. The fact that this important milestone has now been reached can be especially attributed to successful cooperation with our partners, and we would like to thank them for their good collaboration." With the upgrade to the e-health connector, all TI customers of CGM will also have access to the Qualified Electronic Signature (QES) basic service based on the new electronic health professional cards. This provides a legal, secure way to sign documents that are required for things like sending data via the new communication standard called "communication in the medical sector" (KIM). Using KIM, practitioners can exchange information quickly, easily and, above all, securely, across sectors. KIM was also extensively tested in a field test in the North Rhine region and in various practices in Berlin, Baden-Württemberg and Bavaria. The communication service recently received the necessary approval from gematik and can now also be used with the e-health upgrade.About CompuGroup Medical SE & Co. KGaA CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of EUR 746 million in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.5 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 6,100 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.Contact for media representatives: Michael Franz Head of Brand Communication P +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 E-mail: press@cgm.com Contact for analysts and investors: Claudia Thomé Head of Investor Relations P +49 (0) 261 8000-7030 F +49 (0) 261 8000-3200 E-mail: claudia.thome@cgm.com * * *22.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: CompuGroup Medical SE & Co. KGaA Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE000A288904 WKN: A28890 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1099177 End of News DGAP News Service

  • EQS Group

    CompuGroup Medical completes acquisition of parts of Cerner's European hospital information system business

    DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Acquisition 01.07.2020 / 17:07 The issuer is solely responsible for the content of this announcement. * CompuGroup Medical completes acquisition of parts of Cerner's European hospital information system business * Acquisition of parts of the Cerner portfolio in Europe completed * CompuGroup Medical (CGM) becomes the clear number 2 in the German market for hospital information systems * Expansion of the portfolio in Spain; being one of the leading providers of HIS in public hospitals * Hospitals benefit from a combination of hospital information systems and connectivity technologies Koblenz. CompuGroup Medical SE & Co. KGaA (CGM) has acquired parts of Cerner's business in Germany and Spain. The transaction was announced in February and was completed today. The acquired parts of the company will be fully included in the group consolidation as of July 1st, 2020. CGM expects the acquired business activities to deliver a contribution to revenues and EBITDA in the second half of fiscal year 2020 above same period of prior year, including initial synergy effects. For the entire year 2019, revenues of the acquired business area were approximately EUR 74 million, and the EBITDA was at approx. EUR 13 million. Now that the transaction is complete, CGM's portfolio includes medico(R), Soarian Health Archive(R) (S-HA) and Soarian(R) Integrated Care (S-IC), which are leading hospital information systems (HIS) in Germany as well as Selene(R), a leading HIS in Spain. As a result, Koblenz-based CGM, one of the largest providers of eHealth solutions worldwide, assumes a leading position in the European HIS market. Via combination with existing solutions, in particular through better connectivity, additional value will be created for health professionals and patients."With the successful completion of this transaction, we expand our customer base for hospital information systems by more than 300 additional facilities, making us number 2 in Germany and one of the leading providers in public hospitals in Spain," explains Hannes Reichl, Managing Director Hospital Information Systems at CGM. "The combination of medico and Selene with CGM's connectivity services and the innovative CGM CLINICAL modules enables us to create significant, long-term added value for our customers. Medico and Selene customers will still be in the best hands with us in the future. We will continue to offer them their familiar software solutions and our effective service, whilst simultaneously connectivity with the other sectors in healthcare is strengthened - an important step towards universal digital support of the so-called patient journey, i.e. the accompaniment of health care throughout all stages of treatment."As a result of the takeover, around 1.5 million users, including doctors in medical practices and hospitals, dentists, pharmacists, nursing staff and many other healthcare professionals in outpatient and inpatient healthcare facilities, now rely on solutions from CompuGroup Medical. This enables comfortable, coordinated processes between the different parties involved in patient treatment.Frank Gotthardt, Founder and CEO of CGM, emphasizes: "The over 300 additional facilities that can do their important job of helping people even better thanks to intelligent digital technologies, are a good sign for the healthcare system and for everyone. We warmly welcome our approximately 300 new colleagues that bring along valuable specialist and expert knowledge. Around 6,100 employees in 18 countries are now continuously working to make our vision come true: Nobody should suffer or die just because medical information is missing somewhere at some point." About CompuGroup Medical SE & Co. KGaA CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of EUR 746 million in 2019, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.5 million users, including doctors, dentists, pharmacists and other health professionals in inpatient and outpatient facilities. With locations in 18 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverages among eHealth service providers. Approximately 6,100 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system. Contact for media representatives: Michael Franz Head of Brand Communication P +49 (0) 261 8000-6100 F +49 (0) 261 8000-3100 E-mail: press@cgm.com Contact for analysts and investors: Claudia Thomé Head of Investor Relations P +49 (0) 261 8000-7030 F +49 (0) 261 8000-3200 E-mail: claudia.thome@cgm.com * * *01.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: CompuGroup Medical SE & Co. KGaA Maria Trost 21 56070 Koblenz Germany Phone: +49 (0)261 8000 6200 Fax: +49 (0)261 8000 3200 E-mail: investor@cgm.com Internet: www.cgm.com ISIN: DE000A288904 WKN: A28890 Indices: MDAX, TecDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1083757 End of News DGAP News Service

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more